NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company founded in 2000 and headquartered in Emeryville, California. It specializes in the development and commercialization of innovative eyecare, wound care, and skincare products leveraging its patented, stable form of hypochlorous acid. Key products include Avenova for eyelid and lash hygiene, NeutroPhase for wound cleansing, and offerings under the DERMAdoctor brand addressing various skin conditions. Previously known as NovaCal Pharmaceuticals, Inc., the company shifted its name in 2007 to reflect its focus on advanced antimicrobial solutions. Operating within the pharmaceuticals and biotech sector, NovaBay targets eye health, dermatological care, and wound management markets, serving consumers through scientifically proven, clinically validated formulations. With a lean team of approximately 14 employees, it maintains a niche presence in therapeutic personal care, emphasizing purity and efficacy in hypochlorous acid-based technologies to combat infections and promote healing.